1. Emerging insights into pulmonary hypertension: the potential role of mitochondrial dysfunction and redox homeostasis
   Junming Zhang et al, 2024, Molecular and Cellular Biochemistry CrossRef
2. Deciphering the inhibitory effects of trimetazidine on pulmonary hypertension development via decreasing fatty acid oxidation and promoting glucose oxidation
   Asako Yanagisawa et al, 2024, Scientific Reports CrossRef
3. Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension
   Fatemeh Khassafi et al, 2023, Nature Cardiovascular Research CrossRef
4. Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure
   Vasiliki Tsigkou et al, 2023, International Journal of Molecular Sciences CrossRef
5. Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting purine metabolism and polyamine synthesis-associated vascular remodeling
   Yu-jing Chen et al, 2024, International Immunopharmacology CrossRef
6. A multimodal approach identifies lactate as a central feature of right ventricular failure that is detectable in human plasma
   Anna Hemnes et al, 2024, Frontiers in Medicine CrossRef
7. Metabolomics in Pulmonary Hypertension—A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology
   Pier Paolo Bassareo et al, 2023, International Journal of Molecular Sciences CrossRef